Sunil Rajanikant Mehta
Director/Board Member at Emcure Pharmaceuticals Ltd.
Net worth: 111 $ as of 2021-09-29
Sunil Rajanikant Mehta active positions
| Companies | Position | Start | End |
|---|---|---|---|
Emcure Pharmaceuticals Ltd.
 Emcure Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Emcure Pharmaceuticals Ltd. engages in developing, manufacturing and marketing of pharmaceutical products. Its products include Nucron, Xennea, Xennex, Nifirex, Criante and Oncocare. The company offers calcium channel blockers, beta blockers, hypotensive combinations, statins, anti-coagulants, and diuretic combinations for cardiology. Its product portfolio includes orals, injectable and biologics, as well as an mRNA platform through which it is developing a COVID-19 vaccine. The company was founded by Satish Ramanlal Mehta on April 16, 1981 and is headquartered in Pune, India. | Director/Board Member | 2013-06-04 | - |
| Corporate Officer/Principal | 2013-06-04 | - | |
Gennova Biopharmaceuticals Ltd.
 Gennova Biopharmaceuticals Ltd. Miscellaneous Commercial ServicesCommercial Services Gennova Biopharmaceuticals Ltd. specializes in biotechnology research for biosmiliars, vaccines, and mAbs using recombinant DNA technology. The company was founded on June 19, 2001 and is headquartered in Pune, India. | Director/Board Member | 2001-06-18 | - |
Career history of Sunil Rajanikant Mehta
Training of Sunil Rajanikant Mehta
| University of Pune | Undergraduate Degree |
| Institute of Management, Development & Research | Masters Business Admin |
Statistics
International
| India | 5 |
Operational
| Director/Board Member | 2 |
| Corporate Officer/Principal | 1 |
| Undergraduate Degree | 1 |
Sectoral
| Consumer Services | 3 |
| Health Technology | 2 |
| Commercial Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Private companies | 2 |
|---|---|
Emcure Pharmaceuticals Ltd.
Emcure Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Emcure Pharmaceuticals Ltd. engages in developing, manufacturing and marketing of pharmaceutical products. Its products include Nucron, Xennea, Xennex, Nifirex, Criante and Oncocare. The company offers calcium channel blockers, beta blockers, hypotensive combinations, statins, anti-coagulants, and diuretic combinations for cardiology. Its product portfolio includes orals, injectable and biologics, as well as an mRNA platform through which it is developing a COVID-19 vaccine. The company was founded by Satish Ramanlal Mehta on April 16, 1981 and is headquartered in Pune, India. | Health Technology |
Gennova Biopharmaceuticals Ltd.
Gennova Biopharmaceuticals Ltd. Miscellaneous Commercial ServicesCommercial Services Gennova Biopharmaceuticals Ltd. specializes in biotechnology research for biosmiliars, vaccines, and mAbs using recombinant DNA technology. The company was founded on June 19, 2001 and is headquartered in Pune, India. | Commercial Services |
